The new rule would expand access to drugs such as Wegovy and Zepbound for an additional 3.4 million Americans who use Medicare and another 4 million people enrolled in Medicaid.

Summary

The Biden administration proposed requiring Medicare and Medicaid to cover weight loss drugs like Ozempic and Wegovy, reclassifying obesity as a chronic disease to expand access for millions.

This would reduce out-of-pocket costs, but federal spending could rise by $36 billion over a decade.

Critics, like Sen. Bernie Sanders, warn high drug prices could strain the system, while experts argue reduced obesity-related complications may lower long-term healthcare costs.

The plan faces a 60-day comment period, leaving its implementation uncertain under the incoming Trump administration.

  • Chef@sh.itjust.worksEnglish
    0·
    22 days ago

    Couldn’t afford it after the Pharma coupon on their site expired.

    So I found it on the internet from gray market providers.

    Pharmacy = $900 per month

    Gray Market site = $100 per month

    Down 100+ pounds now.

    This shit NEEDS to be covered by insurance. It’s a life changer. Sickening that it’s like $1k in the USA and like $5 in the actual developed world.